Via GraftM is a viable allogenic bone allograft, in full compliance with all FDA guidelines regarding human cells, tissues and cellular tissue-based products, and is intended for use in bone remodeling. Via GraftM contains cellular, bone scaffold, and bone gel components. The bone scaffold is comprised of a proprietary blend of mineralized microparticulate cortical, cancellous and demineralized cortical allograft bone in optimum particle sizes ranging from 100-300 microns. It is offered in 2.5cc, 5.0cc, and 10 cc sizes. Via GraftM bone scaffold, bone gel, and cell mixture allows for a moldable allograft that can easily pass through a large or open bore syringe. The hydrophobic properties of Via GraftM also make it more resistant to lavage.
Via GraftM is prepared with a novel DMSO-free cryoprotectant, which preserves a cell population that includes marrow-isolated adult multilineage inducible (MIAMI) cells. These primitive cells provide properties that, in combination with the osteoconductive, osteoinductive, and osteogenic elements of the graft, enhance the patient’s innate healing process.
Via GraftM provides key elements ideal for bone repair:
- Three dimensional osteoconductive bone scaffold
- Demineralized bone scaffold with osteoinductive potential
Key Features and Benefits include:
- Novel, DMSO-free cryoprotectant that is effective and safe to implant
- Convenient handling and preparation in the OR
- 2-year shelf life
- Preparation time on back table is less than 20 minutes
Potential Applications include:
- Upper Extremity
- Foot and Ankle
- Oral and Maxillofacial
- Orthopaedic Oncology